~~<i id='55C425088A'><strike id='55C425088A'><tt id='55C425088A'><pre id='55C425088A'></pre></tt></strike></i>~~

Home» leisure time» entertainment

entertainment

author：focus 2025-09-27 19:50:51 Page View：5

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to make the FDA’s new prescription one
Next article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

leisure time

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

1:19Ademonstratorrunsonthethirdnightofprotestssparkedbythefatalpoliceshootingofa17-year-olddriverint

Regeneron agrees to White House price limits on anti

RegeneronagreedtopricelimitsforanewCovid-19drugthatwillbedevelopedinpartnershipwiththeDepartmentofHe

Malaria cases in Florida and Texas: Here’s what you need to know

MosquitoscaughtfortestingawaitshipmenttoalabinMcAllen,Texas,inApril2016tobetestedformosquito-bornedi

States increasingly look to regulate hospital facility fees

Hospitalshaveacquiredalotofphysicianofficesandhaveaddedfacilityfeestotheircharges.JEFFPACHOUD/AFPvia

WSS

entertainment

entertainment

knowledge

leisure time

States increasingly look to regulate hospital facility fees